Applied DNA Sciences, Inc. (NASDAQ: APDN) Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $ ...
Dr. Axel Heidenreich presented the final results of the COTRIMS (Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma) trial. Clinical stage (CS) IIA/B seminoma accounts for only 10 ...
The Village Family Service Center's First Step Recovery program is now offering addiction treatment services in a virtual ...
The Faculty of Medicine at Imperial is a world-class teaching, learning and research environment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results